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1193-53 The Impact of Admission to Primary Versus Tertiary 
Care VA Medical Centers on Outcomes Following Acute 
Coronary Syndromes: The VA Access to Cardiology 
Study 
John S. Rumsfeld David J. Magid, Mary E. Plomondon, John M. Westfall, Laura A. 
Peterson, Anne E. Sales, Denver VA Medical Center, Denver, CO, VA Puget Sound 
Health Care System, Seattle, WA 
Background: There is concern that ACS patients admined to primary care hospitals 
(without cardiology services) may be at risk for worse outcomes compared to patients 
admitted to tertiary care hospitals (with cardiology services). We compared the outcomes 
of ACS patients admined to primary versus tertiary Veterans Administration hospitals. 
Methods This was an observational cohort study of 2,322 VA patients with AMI or 
Unstable Angina from 24 VA hospitals (10 tertiary, 14 primary centers). Univariate analy- 
ses were used to compare the baseline characteristics and outcomes of patients admit- 
ted to primary versus tertiary care hospitals. Outcomes included in-hospital and 7-month 
mortality, and 7-month revascularization rates (PCI or CABG surgery). 
Results There were 1470 patients admitted to tertiary centers and 652 patients admitted 
to primary centers, and they had similar baseline characteristics. However, patients 
admitted to primary centers had significantly higher in-hospital and 7.month mortality, 
and lower 7.month revascularization rates (Table). 
Conclusion: Patients admitted to primary care VA hospitals appear to be at increased 
risk for mortality following ACS. This may be due to under-use of revascularization. since 
these patients were 31% less likely to be revascularized within 7 months following ACS 
admission than patients admitted to tertiary hospitals. These results may have important 
implications for how ACS care and revascularization are delivered in the VA. 
In-Hospital Mortality 
7-Month Mortality 
7-Month Revsscularization Rate 
Primary Care Tertiary Care P-value 
5.2% 3.3% 0.03 
12.9% 10.2% 0.05 
21.6% 31.4% <O.OOl 
1193-54 Despite Increased Mortality Post Myocardial Infarction, 
Diabetics Have Made Substantial Gains From Therapy 
Masoor Kamalesh, Anahita Ariana. Usha Subramanian. Stephen Sawada, Krannert 
Institute of Cardiology, Indianapolis. IN 
Background: Mortality from myocardial infarction has declined due to improvements 
in medical therapy. We investigated the gains made by diabetic subjects as compared to 
non-diabetic subjects in mortality post Ml. 
Methods: All veterans hospitalized for acute MI at any veterans affairs medical center 
between 10190 and lo/97 were identified. Demographic, clinical, follow-up and mortality 
data were extracted from the national data base. Mortality at 60 days and 1 year post Ml 
was compared between diabetics and non-diabetics for each year from 1991 to 1996 
Results: A total of 67,869 patients with acute Ml were identified (diabetics=l7,756). At 
60 days, death rate in non-diabetics fell from 14.66% in 1991 to 11.59% in 1996(21% 
reduction). In the diabetic group it fell from 16.23% to 12.55%(22.6% reduction)(See 
table). Relative reduction for 1 year mortality in the same time period was 26% for both 
groups 
Conclusions: Although diabetics continue to have higher mortality post MI compared to 
non-diabetics, there has been significant reduction in mortality in diabetics In the last 
decade. The relative reduction in mortality is similar in both groups. 
Percent dead at 60 days by year 
Year non-diabetic diabetic total mortality 
1991 14.68 16.23 15.04 
1992 13.36 13.60 13.42 
1993 13.14 15.22 13.63 
1994 12.74 14.69 13.25 
1995 12.26 16.27 13.35 
1996 12.39 14.16 12.67 
1997 12.73 14.17 13.14 
1996 11.59 12.55 11.89 
1193-55 Do Hospital Outcomes Differ Among Patients With 
Acute Coronary Syndromes Admitted Directly Versus 
Those Transfeired to a Tertiary Hospital? _ 
Kamala P. Tamirisa, Dean E. Smith, Eduardo Bossone, Jeanna V. Cooper, Jianming 
Fang, Eva Kline-Rogers, Kim A. Eagle, Rajendra H. Mehta. University of Michigan, Ann 
Arbor, MI 
Background: Patients with acute coronary syndromes (ACS) at tertiary hospitals (TH) 
are either admitted directly or transferred from other hospitals for further management. 
However, it is uncertain how these two groups differ in clinical features. treatment and 
outcomes. 
Methods: We reviewed 1146 ACS patients admitted to University of Michigan hospital. 
Results: When compared to direct admits, transferred patients were younger, had lower 
body mass index, less angina and lower incidence of prior bypass surgery or renal fail- 
ure. However, transferred patients had greater ST segment dewtions, troponin eleva- 
tion, cardiac arrest and Killip class at presentation. Transferred patients were also more 
likely to undergo procedures (cardiac catheterization 73% vs. 59%; percutaneous coro- 
nary intervention 47% vs. 34%; pulmonary artery catheterization 14% vs. 6%; intra aortic 
balloon pump 9% vs. 6% 8 ventilator support 17% vs. 6%. p co.05 for all). In-hospital 
events are as shown in Table. 
Conclusions: Patients with ACS transferred to TH have an increased risk profile and as 
a result have higher in-hospital events including mortality compared to those admitted 
directly. Therefore, risk-adjusted, rather than raw percentages, are important for compar- 
ing outcomes of one hospital to another, where the frequency of receiving transferred 
patients can vary widely. 
In-hospital A* De Cardiogeni Sustained Ventricular Ventricular 
Events lnfarcti &h cShock Tachycerdis Fibrillation 
on 
% 3 7 12 6 5 
Transferred 
% Directly 0.5 3 5 3 2 
Admitted 
p Value 0.001 0.0 0.001 0.03 0.006 
03 
1193-56 Management and In-Hospital Outcome for Patients With 
Acute Myocardial Infarction in Contemporary Practice: 
Japan Acute Myocardial Infarction (JAMI) Study-- 
Prospective Multicenter Observational Cohort Study in 
Japan 
Hirotaka Kimura, Hiroshi Kasanuki, Jun-ichi Yamaguchi, Masahiro Yagl, Shtnya Fujii, 
Hiroshi Koaanei. Yasuhiro Ishii. and HIJC Investioators. The Heart Institute of Japan. 
Tokyo Women’s Medical University, Tokyo, Japan 
BACKGROUND: Several studies clarified that race and treatment approaches are impor- 
tant factors for clinical outcomes of acute myocardial infarction (AMI). However, there is 
no large trial that examine the specificity of AMI in Japan. Japan Acute Myocardial Infarc- 
tion (JAMI) Study is a large, prospective, multicenter observational study of patients hos- 
pitalized with AMI in Japan. The aim of this trial is to elucidate patient characteristics, 
treatment practices and in-hospital and post discharge outcomes for patients with AMI in 
Japan. METHODS: A total of 19 hospitals in Japan are collaborating in JAMI. Information 
on patient demographics, clinical characteristics, treatment approaches and in-hospital 
outcomes is collected using a standardized core case report form. RESULTS: A total of 
3029 patients were enrolled from 1999 through 2001. The median age was 69 * 12 years 
with male preponderance (71%), and 652 (26%) patients of them were aged > 75 years. 
Emergency coronary angiography (within 24 hours after Ml onset) was performed In 72% 
of patients and 61% of them were received percutaneous coronary intervention (PCI). 
The PCI was considered successful in 92%, stents were placed in 67%. In-hospital mor- 
tality was 9.7% in overall, whereas 5.6% in successful PCI patients. Main cause of in- 
hospital death was cardiogenic shock (3.3%). Mean hospital stay was 26 f 16 days. Post 
discharge outcomes will be presented. CONCLUSION: The information collected from 
the JAMI study provided important and extensive insights into patient demographics, clin- 
ical characteristics, current treatment approaches and in-hospital outcomes for patients 
with AMI in Japan. The data from JAMI will be a major reference that will establish new 
evidence-based medicine for AMI in Japan. 
1193-57 Increased Body Mass Index Is Associated With Better 
Short- but Not Lona-Term Outcome Followina Acute 
Myocardial Infarction Despite an Increased Risk of 
Recurrent Events 
Anil Niaam, Joseph G. Murphy, Ray W. Squires. Thomas G. Allison, Donald D. Hensrud, 
Brent A. Williams, Stephen L. Kopecky, R. Scott Wright, Mayo Clinic and Foundation, 
Rochester, MN 
Background: Primary prevention studies suggest that a curvilinear relationship exists 
between body-mass index (BMI) and long-term survival. Several reports indicate an 
inverse relationship between obesity and short-term outcome in coronary patients. The 
relationship between BMI and long-term outcome following acute myocardlal infarction 
(AMI) is less well known. 
Methods: We examined BMI and outcome in 941 AMI patients admitted from January 1, 
1986 to April 16. 2001. BMI was stratified as: normal < 25, overweight 25-29.9 and obe- 
sity >= 30 kg/m2. 
Results: Abnormal-BMI patients were younger and had higher rates of diabetes and a 
CAD family history. Six-month survival was bener in those wth an abnormal-BMI: 
Adjusted OR 0.46 (95% Cl 0.25-0.65; P=O.Ol) while survival >6 months was not: 
Adjusted OR 0.62 (0.59-l .15; PcO.25). BMI >35 was associated with poor short-term out- 
come (Figure). The risk of repeat AMI was higher in patients with an increased BMI: 
Adjusted OR 2.18 (I .15-4.12; P=O.O2), and was related to BMI linearly. 
Conclusions: For AMI survivors, the U-shaped relationship between BMI and mortality is 
shifted rightward suggesting that younger age may explain the obesity paradox. How- 
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ever, patients with BMI >25 are at increased risk of recurrent AMI. This finding suggests 
the need to aggressively intervene in obese and overweight patients following the index 
AM1 to reduce the long-term risk of recurrent events. 
(15.6) yrs, 54% female, and 37% AA. AA had higher mean distrust scores than C 
patients (2.6k1.7 vs. 1.5t1.5, p<O.OOOl). AA more often reported that doctors would less 
fully explain research to them (25% vs. 13%. pcO.OOl), use them as guinea pigs without 
consent (73% vs. 50%. p<O.OOl), prescribe medication as a way of experimenting on 
people without their knowledge (59% vs. 26% pcO.OOl), and ask them to join research 
even if It could harm them (26% vs. 16%, p=O.O03). AA also more often believed they 
could less freely ask their doctor questions (8% vs. 2%, p=O.OOl) and were previously 
expenmented on without their consent (55% vs. 45%, p<O.OOi). Fewer AA than C were 
WTP (29% vs. 38%, respectively, p=O.O3); however, this difference was no longer signif- 
icant after controlling for distrust and sociodemographics (OR=0.82, 95% Cl 0.55-1.22). 
Every one-point increase in distrust score predicted a 27% lower odds of WTP, OR=0.73 
(0.65-0.83, p<O.OOl). 
i* 14 
1193-58 What is the Meaning of High-Risk? A Prospective 
Comparison of Three Risk Stratification Models 
Recommended in Non-ST Elevation Myocardiai 
Infarction and Unstable Angina 
Ali F. Sonel, Chester B. Good, Mary E. Kelley, Lauren Wall, Jeffrey Whittle, Michael J. 
Fine. VA Pittsburgh Healthcare System, Center for Health Equity Research and 
Promotion, Pittsburgh, PA, University of Pittsburgh, Pittsburgh, PA 
Background: Non-ST elevation MI (NSTEMI) and unstable angina (UA) patients (pts) 
represent a heterogeneous population. ACC/AHA guidelines for NSTEMI and UA recom- 
mend 3 different risk stratification models (AHCPR, PURSUIT, TIMI). 
Methods: The relative accuracy of each risk model cited by the guidelines was prospec- 
tively studied in 566 pts admitted with suspicion of Ml. Information was obtained from 
chart review and clinical follow up. The end-point was 30-day death or new Ml. 
Results: Mean age was 67 +/- 12 years. The AHCPR Model, PURSUIT Model and the 
TIMI Model identified 85%. 42% and 9% of pts as “high-risk’ respectively. Using only car- 
diac marker and ECG criteria, 63% of pts were identified as high-risk. At 30 days 56 of 
566 patients (10%) had a cardiac event. Among all three model variables, hemodynamic 
instability (p<O.OOi), pulmonary edema (p<O.OOl), cardiac markers (p<O.OOl), age 
(p=O.O35), ST changes (p=O.O5), Canadian Cardiovascular Class Ill-IV (p=O.O36), not 
being on aspirin prior to admission(p=0.015) were predictive of events. 
% Event % Event Sensitivity Specificity p value 
High-Risk Not High-Risk 
AHCPR Model 1 1% 4% 95% 10% 0.031 
PURSUIT Model 14% 8% 57% 60% 0.016 
TIMI Model 10% 10% 9% 91% NS 
ECG and Markers 14% 4% 85% 39% <O.OOl 
Conclusions: Although both the AHCPR Model and the PURSUIT Model were 
predictive of events, the former was non-specific. A model based only on the ECG and 
marker criteria predicted events with good sensitivity and moderate specificity. The TIMI 
Risk score was not predictive of events. Future models for risk stratification should rely 
more on objective markers and ECG criteria and should be derived and validated 
prospectively in a non-selected population of pts. 
ORAL CONTRIBUTIONS 
851 Societal Issues in Outcomes Research 
Tuesday, April 01, 2003, 2:00 p.m.-3:30 p.m. 
McCormick Place, Room S105 
2:00 p.m. 
851-l Effect of Ethnicity on Distrust Toward Medical 
Researchers and Willingness to Join a Cardiovascular 
Drug Prevention Trial 
Joel B. Braunstein, Steven P. Schulman, Neil R. Powe, The Johns Hopkins Medical 
Institutions, Baltimore, MD 
Background: Minority underrepresentatlon exists I” medical research including cardio- 
vascular disease (CVD) clinical trials. We asked whether African-Americans (AA) differ 
from Caucasians (C) in their distrust toward medical researchers and whether this influ- 
ences their willingness to participate (WTP) in a clinical trial. 
Methods: We approached 717 randomly selected patients from 13 Maryland-based out- 
patient cardiology and general medicine clinics between May and August 2002 to com- 
plete a self-administered survey regarding their WTP in a CVD drug prevention trial. 
Patients read a trial description that contained information similar to that in a consent 
form and reported their WTP using a B-point scale. Medical researcher distrust was 
assessed using a previously published 7-point index. We determined the relation 
between ethniclty and distrust, and how these factors influenced WTP, while adjusting for 
soclodemographlcs. 
Results: 595 patients (83% response) completed the survey: mean (SD) age = 53.6 
March 19,2003 
Conclusion: AA express much greater distrust toward medical researchers, and distrust 
IS an important negative predictor of WTP in clinical trials. Greater distrust toward medi- 
cal researchers may paltially explain AA underrepresentation in clinical trials. 
2:15 p.m. 
851-2 Ramifications of Cost-Sharing for 21,732 Patients With 
Congestive Heart Failure: Early Results From the Safety 
and Financial Ramifications of Emergency Department 
Copayments (SAFE) Study 
John Hsu Mary Price, Richard Brand, Bruce Fireman, Joseph P. Newhouse, Joseph V. -I 
Selby, Kaiser Foundation Research Institute, Oakland, CA, Harvard University, 
Cambridge. MA 
Background Millions of Americans are facing Increasing levels of cost-sharing, which 
are designed to promote more efficient resource use, but have unclear clinical conse- 
quences. We investigated the impact of cost-sharing for emergency care on Emergency 
Department (ED) visits and hospitalizations in a cohort of patients with congestive heart 
failure (CHF). Methods As part of an AHRQ-sponsored quasi-experimental study, we 
examined the effect of ED copayment levels on ED visits and hospitalizations during 
1999- 2001 in adult congestive heati failure (CHF) patients. All subjects were members 
of Kaiser Permanent+Norihem California, an integrated, managed care delivery sys- 
tem. We classified ED copayments of $20 or greater as High, and compared the esti- 
mated relative rates of monthly ED use and hospitalizations by copayment level using a 
gamma random effects model, adjusting for age, gender, medical center, a case-mix pro- 
penslty score, baseline cardiovascular medication use, and time. We used the 118 hier- 
archical condition categories (DxCG based HCC’s) to calculate the propensity score. 
Results The 21,732 subjects tended to be male (55%) and 65 years or older (74%; mean 
age 71 years, SD=i2). In 1999, 14% of subjects had High ED copayments; this percent- 
age increased to 60% I” 2000 and 70% in 2001. The number of patients with Medicare 
remained around 67% during the study period; the remainder had commercial prepaid 
Insurance. The mean ED visit and hospitalization rates were 132.2 and 57.8 visits per 
100 person-months respectively. In the multivariate models, subjects with a High ED 
copayment had a relative ED visit rate of 0.97 (95% Cl: 0.95 - 0.99), and hospitalization 
rate of 1 .O (95% Cl: 0.97 - 1 05). Conclusion In chronic disease patients, copayments 
for ED visits were associated with a small decrease in ED use, but were not associated 
with significant changes in hospitalizations. These preliminary data suggest that cost- 
sharing for emergency care could reduce resource consumption and costs without harm- 
ing patients’ health. Additional analyses will investigate changes in other clinical out- 
comes including mortality and in total costs. 
2:30 p.m. 
851-3 influence of Physician Specialty on Care and Outcomes 
of Acute Coronary Syndrome Patients: Results From 
CRUSADE 
Eric D. Peterson, Matthew T. Roe, Yun Li, Robert A. Harrington, Ralph G. Brindls, Sidney 
Smith, W. Brian Gibler, E. Magnus Ohman, Duke Clinical Research Institute, Durham, 
NC 
Background: We investigated the degree to which care of patlents with NSTE acute COT- 
onary syndrome (ACS) varies by the speciality of the primary treating physician. We also 
associated these care differences with acute patient outcomes. Methods: Using the 
CRUSADE National Registry, we examined 18,985 high risk ACS pts with + cardiac 
markers and/or ST depression treated at 289 US hospitals in 2001-02. We compared 12 
class I ACCiAHA guideline cars processes, as well as, in-hospital outcomes by the MD 
primarily responsible for in-hospital care (cardiology vs non-cardiology). Care and out- 
come results were also adjusted for patient casemix and for hospital features (academic 
status, hospital facilities, bed size and % pts treated by cardiology). Results: Overall, 
43% of ACS patients were primarily cared for by non-cardiologists. Table 1 provides 
selected care processes and outcomes by speciality and the adjusted odds ratio for 
receiving that treatment or outcome for cardiologists’ care vs not. Conciusions: Patients 
with NSTE ACS were significantly more likely to receive ACC/AHA guidelines indicated 
treatments if they were cared for by a cardiologist Patients’ acute mortality risks was also 
significantly lower with cardiologist care even after adjusting for presenting clinical factors 
and hospital features. This study demonstrates the need to more widely disseminate 
national cardiac care guidelines for NSTE ACS to all physicians. 
